Troya Therapeutics ApS — Credit Rating and Financial Key Figures

Troya Therapeutics ApS (CVR number: 44032589) is a company from KØBENHAVN. The company recorded a gross profit of -420.8 kDKK in 2023. The operating profit was -420.8 kDKK, while net earnings were -359.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -28.9 %, which can be considered poor and Return on Equity (ROE) was -31.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -22 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Troya Therapeutics ApS's liquidity measured by quick ratio was 64.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.